Ayuda
Ir al contenido

Dialnet


Resumen de Early treatment for alzheimer'S. (cover story)

Emily Laber-Warren

  • This article discusses a study being conducted on an extended family in Colombia aimed at evaluating the ability of crenezumab, a drug created by pharmaceutical company Genentech, to prevent the buildup of amyloid proteins in the brain for the purpose of preventing early-onset Alzheimer's disease.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus